Insights › Market reaction

Why Nurix Therapeutics (NRIX) Stock Fell 35.40% in 10 Minutes on Nov 3, 2026

The 35.40% drop was larger than any reaction MoveSurge measured after Nurix Therapeutics headlines between Aug 5, 2026 and Nov 2, 2026; the largest of those was -3.00% in 10 minutes, on Oct 12, 2026.

Published in ET: Feed time in ET: Company news NRIX -35.40% in 10 min after the headline
  • NRIX fell 35.40% in the 10 minutes after the 16:01:04 ET headline, from $25.82 to $16.68.
  • 219,530 shares changed hands in those 10 minutes.
  • The headline crossed in after-hours trading, 1 minute after the 4:00 ET close.
NRIX Why Nurix Therapeutics (NRIX) Stock Fell 35.40% in 10 Minutes on Nov 3, 2026
MoveSurge publish 16:01:04 ET
MoveSurge publish
16:01:04 ET
26.66 22.74 18.70 14.78 15.81 15:59 16:01 16:13
Real 1-minute OHLC candles around publish time. Chart times are New York ET; validated market data captured by MoveSurge.

Reaction by asset (real prices)

Asset2m beforeAt release+1m+10m+1m %+10m %
NRIX 25.82 25.82 20.05 16.68 -22.35% -35.40%

Nurix Therapeutics (NRIX) shares fell 35.40% in the 10 minutes after this headline reached the MoveSurge news feed at 16:01:04 ET on Tuesday, November 3, 2026: “Nurix Therapeutics says Sanofi will stop developing STAT6 degrader SAR448272”

NRIX in the first 10 minutes

From a reference price of $25.82 just before the headline, the stock was down 22.35% after one minute and down 35.40%, at $16.68, after 10 minutes. The move kept building after the first minute. 219,530 shares changed hands in those 10 minutes. The headline crossed in after-hours trading, 1 minute after the 4:00 ET close.

Earlier NRIX headlines and the measured reaction

The 35.40% drop was larger than any reaction MoveSurge measured after Nurix Therapeutics headlines between Aug 5, 2026 and Nov 2, 2026; the largest of those was -3.00% in 10 minutes, on Oct 12, 2026.

  1. Oct 12, 2026, 16:08 ET: “Nurix Therapeutics (NRIX) Fiscal Q3 earnings results” (-3.00% in 10 minutes)

Nurix Therapeutics at a glance

SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
Market value$2.96 billion (as of Nov 1, 2026)

Prices are closes of 1-minute bars. Each move on this page is measured from the last completed bar before its headline.

What headline moved Nurix Therapeutics stock on November 3, 2026?

At 16:01:04 ET, this headline crossed: “Nurix Therapeutics says Sanofi will stop developing STAT6 degrader SAR448272”. The stock fell 35.40% in the next 10 minutes.

How far did NRIX move after the headline?

From $25.82 just before the headline to $16.68 10 minutes later, a -35.40% move.

Sources

Never miss the next market-moving story

Follow the core market-moving feed across equities, macro, currencies and commodities. Your subscription includes price moves after the news, search, watchlists, alerts and research tools.

Go live — 7 days for $29 Watch live headlines -- free
See live news
The next market-moving story will not wait

See the important story while it still matters.

Seven market specialists bring experience dating back to 2006. MoveSurge adds the speed, coverage, and clear format built for today’s market.

Core market coverageEquities, macro, currencies and commodities Clear in secondsThe story, source, context, and measured move together Built on evidenceReal headlines, timestamps, prices, and trusted sources
Go real time View the live feed Subscription renews automatically. Cancel before renewal. Information only—no trade calls.